Biotronik Prepares For Next Era Of Drug-Eluting Stents

Biotronik is touting successful clinical trial results with its Orsiro sirolimus-eluting coronary stent while continuing to develop a resorbable stent.

Orsiro drug-eluting stent
BIotronik's Orsiro Ultrathin Strut Sirolimus-Eluting Coronary Stent • Source: Biotronik

More from Clinical Trials

More from R&D